a r t i c l e i n f o a b s t r a c t 24 It is often an immense challenge to overexpress human membrane proteins at levels sufficient for struc- 25 tural studies. The use of Human Embryonic Kidney 293 (HEK 293) cells to express full-length human 26 membrane proteins is becoming increasingly common, since these cells provide a near-native protein 27 folding and lipid environment. Nevertheless, the labor intensiveness and low yields of HEK 293 cells 28 and other mammalian cell expression systems necessitate the screening for suitable expression as early 29 as possible. Here we present our methodology used to generate constructs of human membrane proteins 30 and to rapidly assess their suitability for overexpression using transiently transfected, glycosylation- to overexpress a wide variety of mammalian membrane proteins 47 [1] [2] [3] , including that of human Rh family, C Glycoprotein (RhCG) 48 whose X-ray crystal structure was recently determined in our lab-49 oratory [4] . proteins from HEK 293S cell cultures, nevertheless, the cloning pro-120 tocol described below can in principle be applied to any affinity tag 121 that is short enough to be introduced via a PCR primer (Table 1) .
122
This may be of benefit given the pronounced effect that both affinity blotting against N-terminal affinity tags ( Fig. 2 MV-tetO using the same methodology as described here. Membranes were probed using an anti-FLAG-HRP monoclonal antibody (1:1000 dilution). is traditionally used to assess the quality of the target gene [13] . 365 We find that FSEC can be used in a quantitative manner (Fig. 5A ) 366 to assist in the determination of expression levels along with (Fig. 5B) . We find that expression levels are best evaluated by nor-374 malizing the area of the included FSEC peak to the area of the 375 absorbance at 280 nm (A280) chromatogram (Fig. 5A , 5B). This 376 normalization is performed to account for differences in cell count 377 among the separate transient transfections.
378
In FSEC, as is the case for standard size exclusion chromatogra- In both cases, whole cell membrane solubilized material (using 1% b-DDM) was resolved on a reducing SDS-PAGE, and immunoblotted using an anti-FLAG (HRP) monoclonal antibody. For the HEK 293S expression trials, each lane corresponds to a clonal cell line stably transformed with transgene subcloned into pACMV-tetO. For Sf9 expression, the transgene was expressed using a pFASTBac expression vector (Invitrogen, 10712024), followed by a P2 viral dilution of either 1:200, or 1:500 for infection. In the case of the Sf9 produced material, both higher order aggregates (>250 kDa) and degradation products (20 kDa) were observed, in addition to the expected 60 kDa band, suggesting that Sf9 may not be suitable for the expression of this human solute carrier family member. While higher order aggregates ($150 kDa) were also observed in HEK-293S, their magnitude relative to the 60 kDa band appeared to be less for some clonal cell lines (see clones 4, 6 and 9) relative to that observed for Sf9 (see 1:200 dilution).
